Search research articles
Contact Us
Filters
Showing results (91-100 of 484) with videos related to
Page
of 49
Sort By:
Expert Opinion on Drug Safety
|
October 24, 2014
A safety evaluation of canagliflozin : a first-in-class treatment for type 2 diabetes
Luke D Boyle, John P H Wilding
The Journal of Infectious Diseases
|
January 1, 1994
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma
H Wang, R Lottenberg, M D Boyle
Biochemical and Biophysical Research Communications
|
May 14, 1980
Evidence for a temperature-dependent and temperature-independent pathway in the generation of complement-mediated transmembrane channels
M Okada, M D Boyle, T Borsos
Expert Opinion on Emerging Drugs
|
August 24, 2013
Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes
Luke D Boyle, John P H Wilding
Gastroenterology
|
December 1, 1970
A controlled clinical trial of lactulose in hepatic encephalopathy
F Simmons, H Goldstein, J D Boyle
The Journal of Infectious Diseases
|
January 1, 1995
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci
H Wang, R Lottenberg, M D Boyle
Journal of the National Cancer Institute
|
March 1, 1976
Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment
M D Boyle, S H Ohanian, T Borsos
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1976
Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells
M D Boyle, S H Ohanian, T Borsos
Clinical Immunology and Immunopathology
|
September 1, 1981
Heterogeneity in the size and stability of transmembrane channels produced by whole complement
M D Boyle, A P Gee, T Borsos
Molecular Immunology
|
July 1, 1981
Differences in the functional activity of human and guinea pig C1 based on their reactivity with IgG at low temperature
A P Gee, M D Boyle, T Borsos
Page
of 49
Search research articles
Search
Showing results (91-100 of 484) with videos related to
Sort By:
Page
of 49
Expert Opinion on Drug Safety
|
October 24, 2014
A safety evaluation of canagliflozin : a first-in-class treatment for type 2 diabetes
Luke D Boyle, John P H Wilding
The Journal of Infectious Diseases
|
January 1, 1994
Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma
H Wang, R Lottenberg, M D Boyle
Biochemical and Biophysical Research Communications
|
May 14, 1980
Evidence for a temperature-dependent and temperature-independent pathway in the generation of complement-mediated transmembrane channels
M Okada, M D Boyle, T Borsos
Expert Opinion on Emerging Drugs
|
August 24, 2013
Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes
Luke D Boyle, John P H Wilding
Gastroenterology
|
December 1, 1970
A controlled clinical trial of lactulose in hepatic encephalopathy
F Simmons, H Goldstein, J D Boyle
The Journal of Infectious Diseases
|
January 1, 1995
A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci
H Wang, R Lottenberg, M D Boyle
Journal of the National Cancer Institute
|
March 1, 1976
Detection of complement-dependent antibody to tumor cells in sera of strain-2 guinea pigs cured of their tumors by BCG Treatment
M D Boyle, S H Ohanian, T Borsos
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 1976
Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells
M D Boyle, S H Ohanian, T Borsos
Clinical Immunology and Immunopathology
|
September 1, 1981
Heterogeneity in the size and stability of transmembrane channels produced by whole complement
M D Boyle, A P Gee, T Borsos
Molecular Immunology
|
July 1, 1981
Differences in the functional activity of human and guinea pig C1 based on their reactivity with IgG at low temperature
A P Gee, M D Boyle, T Borsos
Page
of 49